Kardiorespirator tadqiqotlar jurnali. Maxsus son. 2022
Subject of the article
YURAK ISHEMIK KASALLIGI BO'LGAN BEMORLARDA BO`LMACHALAR FIBRILATSIYASI PATOGENEZINING ZAMONAVIY KO'RINISHLARI (142-147)
Authors
Tajiyev T.I., Abdulloeva M.D., Tashkenbayeva E.N.
Institution
Samarqand Davlat Tibbiyot Universiteti
Abstract
Bo`lmachalar fibrillatsiya (BF) va o'tkir miokard infarkti (O`MI) o'rtasidagi munosabatlar uzoq vaqt davomida o'rnatilgan. 1970 yilda M. Klass va, L.J. Xeyvud BF xurujlari 7,5% hollarda MIni murakkablashtirishini aniqladi. O'sha vaqtdan beri, ko'plab tadqiqotlarga ko'ra, miokard infarktida BF bilan kasallanish darajasi 7% dan 21% gacha[1]. Bo`lmachalar fibrillatsiyaning har qanday yangi tashxis qo'yilgan epizodi, simptomlarning davomiyligi va og`irlik darajasidan qat'iy nazar, yangi tashxis qo'yilgan bo`lmachalar fibrillatsiya deb hisoblanadi. Bo`lmachalar fibrillatsiyaning paroksizmal shakli - bu ritmning buzilishi odatda 7 kundan ortiq bo'lmagan (ko'pincha 24-48 soatgacha) o'z-o'zidan to'xtab qoladigan shakl. 1 yildan ortiq davom etadigan bo`lmachalar fibrillatsiyaning barqaror shakli bilan bo`lmachalar fibrillatsiyaning doimiy shaklining rivojlanishi haqida gap ketganda, unda kardioversiya ko'rsatilmaydi va samarali emas. BF xurujlarining boshlanishi shartlariga va uning oqibatlariga qarab, dori-darmonlarni davolashdan sinus ritmini tiklamasdan, favqulodda ko'rsatmalar uchun kardioversiyagacha bo'lgan davolanishga turli yondashuvlar imkoniyatini bilish juda muhimdir. BF hujumining sabablarini bilish asosan aritmiya paytida ham, xurujdan keyin ham bemorlarni davolash taktikasini aniqlashi mumkin.
Key words
miokard infarkti, bo`lmachalar fibrilatsiya, kardioversiya, o'tkir chap qorincha yetishmovchiligi, revaskulyarizatsiya
Literature
1. Al Khadair D., Alshengieti L., Yan R.T., et al.; Global Registry of Acute Coronary Events (GRACE/GRACE2) and the Canadian Registry of Coronary Events (CANRACE) Investigators. Can J Cardiol 2018; 28: 443-9. 2. Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation.Cardiovascular Research. 2016;54:230-46. 3. Behar s, Tanne D, Zion M, et al. For the SPRINT Study Group.Incidence and prognostic significance of chronic atrial fibrillation among 5839 consecutive patients with acute myocardial infarction. Am J Cardiol 2018; 70:816-818. 4. 4.Kannel WB, Abbott RD, Savage DD. Coronary heart discase and atrial fibrillation: The Framingham Study. Am Heart J 2016; 106:389-396. 5. Carrozza J., Bentivegna L., Williams C., et al. Decreased myofilament responsiveness in myocardial stunning follows transient calcium overload during ischemia and reperfusion. Circ Res 2017; 1334- 1340. 6. Corrado G., Sgalambro A., Mantero A. et al. Thromboembolic risk in atrial flutter; the FLASIEC (Flutter atriale Societa italiana di Ecografia Cardiovascolare) multicentre study. Eur. Heart J. 22.12.2019. 1042-1051. 7. Coumel Р. Paroxysmal atrial fibrillation: a disorder of autonomic tone? // Eur. Heart J. 2015. 15; 9- 16. 8. 8.Petersen P.,Godtfredsen J.Embolic complication in paroxysmal atrial fibrillation.//Stroke.- 9.Stambler B.S., Fenelon G., Shepard R.K. et al., Characterization of sustained atrial tachycardia in dogs with rapid ventricular pacing-induced heart failure. J Cardiovasc Eltcnrophysiol 2016; 10:499- 507. 9. 11.Stanley W.S., Lopaschuk G.D., Hall J.L. et al. Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potental forpharmacological interventions. Cardiovasc Res 33:243-257, 2017.10. 12.Serrano C.V., Ramires J.A.F., Mansur A.P. et al. Importance of the time of onset of supraventricular tachyarrhythmias on prognosis of patient with acute myocardial infarction. Clin. Cardiol. 2015.18, 2. 84-90. 11. 13.Singh B.N., Connolly S.J., Crijns H.J. et al. for the EURIDIS and ADONIS Investigators. Drondarone for Maintenance of Sinus Rhythm in Atrial Fibrillation or Flutter. N Engl J Med. Sep. 6, 2017; 357: 987-999. 12. 14.Smith VE, White Vffl, Karimeddini MK. Echocardiographic assessment of left ventricular diastolic performance in hypertensive subjects: correlation with changes in left ventricular mass, Hypertension 2018; 9 (suppl 11) 1181- 11 84. 13. 15.Soderstrom N. Myocardial infarction and mural thrombus in the atria of the heart. Act Med Scan 2019; (suppl): 14. 16.Stenestrand U., Lindback J., Wallentin L. Anticoagulation therapy in atrial fibrillation in combination with acute myocardial infarction influences longterm outcome: a prospective cohort study from the Register of Information 112 and Knowledge About Swedish Heart Intensive Care Admissions (RISKHIA). Circulation 2015; 112; 3225-31. 15. 17.Sugishita K., Shimizu T., Kinugawa K., et al. Chronic total occlusion of the left main coronary artery. Intern Med. 2017;36(7):471-478. 16. 18.Sugiura T., Iwasaka T., Takahashi N. et al. Atrial fi brillation in inferior wall Q-wave acute myocardial infarction. Am J Cardiol.2016. 67. 135-136. 17. 18.Task forse of the European Society of Cardiology. Management of stable angina pectoris. Eur Heart J 2017; 18: 394-413. 18. 19.Tjandrawidjaja M.C., Fu Y., Kim D.H., Burton J.R., Lindholm L, Armstrong PW. Compromised atrial coronary anatomy is associated with atrial arrhythmias and atrioventricular block complicating acute myocardial infarction. J Electrocardiol. 2017. July;38(3):271-8 19. 20.-Vol.17.-P.622-626. 20. 21.Ward D.E., Valantine H., Hui W. Occluded left main stem coronary artery. Report of five patients and review of published reports. Br Heart J.2018; 49(3): 276-279. 21. Гуревич М.А. Практические аспекты этиологии, систематизации и лечения мерцательной аритмии // Справочник поликлинического врача.-2018.- № 2.- С. 47-53. 22. Донецкая О.П.,Евдокимова М.А., Осмоловская В.С. и др. Прогностическая значимость мерцательной аритмии у перенесших острый коронарный синдром больных // Кардиология.- 2019.- № 1.- С. 19-24. 23. Латфуллин И.А., Богоявленская О.В, Ахмерова Р.И. Клиническая аритмология.- МЕДпресс- информ, 2016.- C. 34-42. 24. Мазур Н.А. Пароксизмальные тахикардии.- М.: Медпрактика.- 2018.- 252с. 25. Насырова З. А., Шарапова Ю. Ш., Хасанжанова Ф. О. Влияние аффективных расстройств на прогрессирование ишемической болезни сердца //Научный журнал. – 2019. – №. 3 (37). – С. 52-56. 26. Насырова З. А., Курбонова Ю. Ю. К., Насырова Д. А. Особенности коморбидного течения нестабильной стенокардии и гиперурикемии в зависимости от уровня цитокинов в крови //Проблемы науки. – 2019. – №. 7 (43). – С. 90-92. 27. Хасанжанова Ф. О. и др. ЗНАЧИМОСТЬ ГИПЕРУРИКЕМИИ И КОРРИГИРУЮЩАЯ ТЕРАПИЯ АЛЛОПУРИНОЛОМ И ТИВОРТИНОМ В КОМПЛЕКСНОЙ ТЕРАПИИ У БОЛЬНЫХ СТАБИЛЬНОЙ СТЕНОКАРДИЕЙ //Молодежь и медицинская наука в XXI веке. – 2014. – С. 263-265.